Aperio Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $619K | Sell |
39,695
-1,621
| -4% | -$25.3K | ﹤0.01% | 1855 |
|
|
2020
Q3 | $390K | Sell |
41,316
-273
| -0.7% | -$2.58K | ﹤0.01% | 1955 |
|
|
2020
Q2 | $373K | Buy |
41,589
+7,358
| +21% | +$66K | ﹤0.01% | 1917 |
|
|
2020
Q1 | $218K | Buy |
+34,231
| New | +$218K | ﹤0.01% | 2067 |
|
|
2019
Q3 | – | Sell |
-12,304
| Closed | -$133K | – | 2678 |
|
|
2019
Q2 | $133K | Sell |
12,304
-2,785
| -18% | -$30.1K | ﹤0.01% | 2308 |
|
|
2019
Q1 | $144K | Buy |
15,089
+1,045
| +7% | +$9.97K | ﹤0.01% | 2208 |
|
|
2018
Q4 | $161K | Buy |
14,044
+3,108
| +28% | +$35.6K | ﹤0.01% | 2175 |
|
|
2018
Q3 | $185K | Buy |
10,936
+843
| +8% | +$14.3K | ﹤0.01% | 2199 |
|
|
2018
Q2 | $143K | Sell |
10,093
-1,551
| -13% | -$22K | ﹤0.01% | 2203 |
|
|
2018
Q1 | $221K | Sell |
11,644
-1,695
| -13% | -$32.2K | ﹤0.01% | 2098 |
|
|
2017
Q4 | $219K | Buy |
13,339
+1,158
| +10% | +$19K | ﹤0.01% | 2111 |
|
|
2017
Q3 | $183K | Sell |
12,181
-110
| -0.9% | -$1.65K | ﹤0.01% | 2132 |
|
|
2017
Q2 | $108K | Buy |
+12,291
| New | +$108K | ﹤0.01% | 2172 |
|